Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loebinger

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|July 6, 2019
Time trends in diagnostic testing for primary ciliary dyskinesia in EuropeFlorian S Halbeisen, Amelia Shoemark, Angelo Barbato, et al.
ERJ Open Research|March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research networkMerete B Long, Jaa Ming New, Jamie Stobo, et al.
ERJ Open Research|October 21, 2020
Multiple breath washout in bronchiectasis clinical trials: is it feasible?Katherine O'Neill, Kathryn Ferguson, Denis Cosgrove, et al.
European Journal of Human Genetics : EJHG|April 11, 2024
Combined approaches, including long-read sequencing, address the diagnostic challenge of HYDIN in primary ciliary dyskinesiaAndrew Fleming, Miranda Galey, Lizi Briggs, et al.
ERJ Open Research|December 31, 2025
Molecular endotyping in people with bronchiectasis based on response to antibiotic treatment: iBEST studyGisli G Einarsson, Laura J Sherrard, Andrew J Lee, et al.
The European Respiratory Journal|May 21, 2026
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?James D Chalmers, Charles S Haworth, Patrick Flume, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT StudyAngelina L P Pieters, Tjeerd van der Veer, Jennifer J Meerburg, et al.
BMJ Open Respiratory Research|January 29, 2019
British Thoracic Society guideline for bronchiectasis in adultsAdam T Hill, Anita L Sullivan, James D Chalmers, et al.
Chest|December 17, 2017
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective BronchiectasisPallavi Bedi, James D Chalmers, Pieter C Goeminne, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE StudyHayoung Choi, Hollian Richardson, Chandani Hennayake, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|July 6, 2019
Time trends in diagnostic testing for primary ciliary dyskinesia in EuropeFlorian S Halbeisen, Amelia Shoemark, Angelo Barbato, et al.
ERJ Open Research|March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research networkMerete B Long, Jaa Ming New, Jamie Stobo, et al.
ERJ Open Research|October 21, 2020
Multiple breath washout in bronchiectasis clinical trials: is it feasible?Katherine O'Neill, Kathryn Ferguson, Denis Cosgrove, et al.
European Journal of Human Genetics : EJHG|April 11, 2024
Combined approaches, including long-read sequencing, address the diagnostic challenge of HYDIN in primary ciliary dyskinesiaAndrew Fleming, Miranda Galey, Lizi Briggs, et al.
ERJ Open Research|December 31, 2025
Molecular endotyping in people with bronchiectasis based on response to antibiotic treatment: iBEST studyGisli G Einarsson, Laura J Sherrard, Andrew J Lee, et al.
The European Respiratory Journal|May 21, 2026
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?James D Chalmers, Charles S Haworth, Patrick Flume, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT StudyAngelina L P Pieters, Tjeerd van der Veer, Jennifer J Meerburg, et al.
BMJ Open Respiratory Research|January 29, 2019
British Thoracic Society guideline for bronchiectasis in adultsAdam T Hill, Anita L Sullivan, James D Chalmers, et al.
Chest|December 17, 2017
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective BronchiectasisPallavi Bedi, James D Chalmers, Pieter C Goeminne, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE StudyHayoung Choi, Hollian Richardson, Chandani Hennayake, et al.
Pageof 15